Prevention of hepatocellular carcinoma resulting from hepatitis B: are we there yet?
Clin Gastroenterol Hepatol
.
2014 May;12(5):894-6.
doi: 10.1016/j.cgh.2013.11.027.
Epub 2013 Dec 4.
Author
Adrian M Di Bisceglie
1
Affiliation
1
Department of Internal Medicine, St. Louis University Liver Center, St. Louis, Missouri.
PMID:
24316105
PMCID:
PMC5497489
DOI:
10.1016/j.cgh.2013.11.027
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents / therapeutic use*
Carcinoma, Hepatocellular / epidemiology*
Female
Hepatitis B, Chronic / complications*
Hepatitis B, Chronic / drug therapy*
Humans
Liver Neoplasms / epidemiology*
Male
Substances
Antiviral Agents
Grants and funding
U01 DK082871/DK/NIDDK NIH HHS/United States